XORTX Therapeutics Inc. filed a Form 6-K on January 3, 2024, indicating compliance with SEC regulations for foreign private issuers. This filing does not report any significant changes or events for the company at this time.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.